Gupta Samir K, Komarow Lauren, Gulick Roy M, Pollard Richard B, Robbins Gregory K, Franceschini Nora, Szczech Lynda A, Koletar Susan L, Kalayjian Robert C
Indiana University School of Medicine, Wishard Hospital, Indianapolis, IN 46202, USA.
J Infect Dis. 2009 Aug 15;200(4):614-8. doi: 10.1086/600890.
Because both renal disease and immune activation predict progression to acquired immunodeficiency syndrome (AIDS), we evaluated the associations between proteinuria>or=1+, as determined by dipstick analysis (7 [7%] of 1012 subjects); creatinine clearance of <90 mL/min (195 [18%] of 1071 subjects); and percentages of peripheral activated CD8 cells (CD8+CD38+HLA-DR+ cells) in antiretroviral-naive, human immunodeficiency virus (HIV)-infected subjects who were enrolled in AIDS Clinical Trials Group studies 384 and A5095. Proteinuria, but not creatinine clearance, was associated with higher percentages of CD8+CD38+HLA-DR+ cells (55% vs. 50%; P=.01), with even more pronounced differences noted among men and among blacks and Hispanics. Proteinuria may be a surrogate measurement of greater immune activation in HIV-infected patients initiating antiretroviral therapy.
由于肾脏疾病和免疫激活均预示着会进展为获得性免疫缺陷综合征(AIDS),我们评估了1012名受试者中通过试纸分析测定蛋白尿≥1+(7人[7%])、1071名受试者中肌酐清除率<90 mL/分钟(195人[18%])与参与艾滋病临床试验组研究384和A5095的未接受抗逆转录病毒治疗的人类免疫缺陷病毒(HIV)感染受试者外周活化CD8细胞(CD8+CD38+HLA-DR+细胞)百分比之间的关联。蛋白尿而非肌酐清除率与较高百分比的CD8+CD38+HLA-DR+细胞相关(55%对50%;P = 0.01),在男性以及黑人和西班牙裔中差异更为明显。蛋白尿可能是开始抗逆转录病毒治疗的HIV感染患者免疫激活增强的替代指标。